Towards a pain free hospital: article published by UMS members in the British Journal of Pain

UMS member, Professor Peacock, and UMS associate member, Dr Sauzet in collaboration with colleagues published a qualitative analysis of pain experiences for head and neck cancer patients in the British Journal of Pain.

‘Towards a pain free hospital: an in-depth qualitative analysis of the pain experiences of head and neck cancer patients undergoing radiotherapy’ found that ‘the specific issues faced by head and neck cancer patients undergoing radiotherapy high- light the need for pain relieving interventions delivered by pain specialists, in tandem with the development of robust self-management strategies.

British Journal of Pain September 23, 2015


Dr Wang and team publish new research in British Journal of Cancer

MedStats team member Dr Wang along with other colleagues published:

‘The impact of low grade toxicity in older people with cancer undergoing chemotherapy’.

The purpose ‘of this observational cohort study was to identify which level of toxicity triggers treatment modification and early discontinuation of chemotherapy in older people.’

The study found that ‘treatment modifications due to toxicity occurred in 60 (55.6%) patients, 35% (21/60) of whom had no greater than grade 2 toxicity.’ ‘Further work is required to clarify whether low-grade toxicity has a greater clinical impact in older people, or whether clinicians have a lower threshold for modifying/discontinuing treatment in older people.’

Professor Prevost investigates a Specialist Breathlessness Service amongst patients with advanced cancer

Professor Prevost along with co-authors has been published in BMC Medicine. The study is titled:

Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial.

The study consisted of a single-centre Phase III fast-track single-blind mixed-method RCT comparing the Breathlessness Intervention Service (BIS) with standard care. The study concluded that ‘BIS appears to be more effective and cost-effective in advanced cancer than standard care’.